Wilson Wai-Shun Cheung insider trades: Sciclone Pharmaceuticals (SCLN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Wilson reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 12, 2017 | SCLN | ↓ Sell | 40,500 | $10.75 | $435K | Direct | Jun 14, 2017 (2d) |
| Oct 26, 2016 | SCLN | ↓ Sell | 149,962 | $10.00 | $1.5M | Direct | Oct 27, 2016 (1d) |
| Oct 17, 2016 | SCLN | ↓ Sell | 1,475 | $10.00 | $15K | Direct | Oct 19, 2016 (2d) |
| Aug 29, 2016 | SCLN | ↓ Sell | 1,872 | $10.35 | $19K | Direct | Aug 29, 2016 (0d) |
| Aug 16, 2016 | SCLN | ↓ Sell | 7,802 | $10.62 | $83K | Direct | Aug 16, 2016 (0d) |
| Nov 10, 2015 | SCLN | ↓ Sell | 7,803 | $9.51 | $74K | Direct | Nov 10, 2015 (0d) |
| Mar 12, 2015 | SCLN | ↓ Sell | 7,803 | $9.07 | $71K | Direct | Mar 16, 2015 (4d) |
| Nov 10, 2008 | AXTI | ↑ Buy | 1,000 | $1.26 | $1K | Direct | Nov 10, 2008 (0d) |
| May 1, 2008 | AXTI | ↓ Sell10b5-1 | 16,600 | $5.11 | $85K | Direct | May 2, 2008 (1d) |
| Apr 28, 2008 | AXTI | ↓ Sell10b5-1 | 3,400 | $5.00 | $17K | Direct | Apr 29, 2008 (1d) |
| Apr 7, 2008 | AXTI | ↓ Sell10b5-1 | 10,000 | $5.00 | $50K | Direct | Apr 8, 2008 (1d) |
| Mar 27, 2008 | AXTI | ↓ Sell10b5-1 | 9,000 | $5.01 | $45K | Direct | Mar 28, 2008 (1d) |
| Mar 24, 2008 | AXTI | ↓ Sell10b5-1 | 1,000 | $5.00 | $5K | Direct | Mar 26, 2008 (2d) |
| Mar 6, 2008 | AXTI | ↓ Sell10b5-1 | 10,000 | $5.03 | $50K | Direct | Mar 10, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Wilson Wai-Shun Cheung's insider trades
Wilson Wai-Shun Cheung is CFO & Senior VP, Finance at Sciclone Pharmaceuticals (SCLN). Since Mar 6, 2008, Wilson has reported 1 open-market purchase worth $1K and 13 sales worth $2.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (10% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (15 filings), grants and awards (12 filings), shares withheld for taxes (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.